Premium
Unbalanced translocation t(5;17) in an atypical acute promyelocytic leukemia
Author(s) -
Brunel Véronique,
Sainty Danielle,
Carbuccia Nadine,
Arnoulet Christine,
Costello Régis,
Mozziconacci MarieJöelle,
Simonetti Jacqueline,
Coignet Lionel,
Gabert Jean,
Stoppa AnneMarie,
Birg Françoise,
LafagePochitaloff Marina
Publication year - 1995
Publication title -
genes, chromosomes and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.754
H-Index - 119
eISSN - 1098-2264
pISSN - 1045-2257
DOI - 10.1002/gcc.2870140410
Subject(s) - chromosomal translocation , acute promyelocytic leukemia , fusion gene , fluorescence in situ hybridization , biology , chromosomal rearrangement , karyotype , breakpoint , retinoic acid , gene rearrangement , microbiology and biotechnology , chromosome 15 , promyelocytic leukemia protein , cancer research , retinoic acid receptor alpha , phenotype , leukemia , chromosome , genetics , gene , retinoic acid receptor
Acute promyelocytic leukemia (APL; M3 in the FAB classification) is specifically associated with the t(15;17)(q23;q12) and the consequent formation of a PML/RARA fusion gene. A few cases of APL with a t(11;17)(q23;q12) and a PLZF/RARA fusion gene have recently been reported. In addition, a new variant, t(5;17)(q32;q12), with a RARA rearrangement was described in a child with atypical APL. We report an unbalanced der(5)t(5;17) in an atypical APL case showing unusual dysgranulopoiesis and some M2 features. The breakpoints were difficult to localize precisely on chromosome 5, because the translocation may have occurred on a previous del(5q). The karyotype also showed del(8q) and multiple double‐minutes (dmin). Molecular studies evidenced RARA rearrangement but showed neither PML rearrangement nor PML/RARA fusion. Fluorescence in situ hybridization revealed that the dmin were of chromosome 8 origin and that they accounted for the MYC amplification observed in Southern blots. The patient did very poorly despite chemotherapy and all‐trans retinoic acid (ATRA) treatment. Thus, the t(5;17) could represent a second type of variant translocation in APL that, like the disease associated with t(11;17), does not seem to respond to ATRA therapy. Whereas RARA rearrangement appears sufficient for an APL‐like phenotype, it seems that the presence of a classical PML/RARA is required for typical APL with response to ATRA.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom